spot_img
Supported byspot_img

Serbian pharmaceutical companies rising profile

Certification company SGS issued ISO 9001:2000, ISO 14001 and OHSAS 18001 certificates to Zdravlje Actavis. Zdravlje Actavis is in the final phase of modernization of production in accordance with the highest world standards. Executive Manager Goran Stojiljkovic said that €33m have been invested in modernization of company.

Company IN MED from Belgrade is building a factory for production of capsules and pills in Zrenjanin. The investor stated that the total cost of construction will be around €2m and 40 pharmacists will be employed.

(SIEPA)

Suppported byOwner's Engineer

Serbia to issue dinar bonds in 2025 and 2026: Key details for investors

The Republic of Serbia plans to issue dinar bonds totaling 120 billion dinars (just over one billion euros) in 2025 and 2026. These bonds...

Economist suggests Serbia should become majority owner of NIS to address U.S. sanctions

Economist Ljubodrag Savić commented on the recent U.S. sanctions imposed on the Serbian oil company, Naftna Industrija Srbije (NIS), suggesting that the best solution...

Serbia’s gas reserves adequate for winter, long-term supply talks in progress

Vojislav Vuletić, the President of the Gas Association of Serbia, stated today that the 426 million cubic meters of gas in Serbia’s reserves are...
Supported byspot_img
Supported byspot_img
Supported byspot_img
error: Content is protected !!